540 related articles for article (PubMed ID: 18288733)
21. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
Spies C; Reissmann U; Timmermanns I; Schräder R
J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
23. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
25. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
26. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
28. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
[TBL] [Abstract][Full Text] [Related]
30. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure.
Durongpisitkul K; Tang NL; Soongswang J; Laohaprasitiporn D; Nana A; Kangkagate C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S658-66. PubMed ID: 12403244
[TBL] [Abstract][Full Text] [Related]
31. Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
Musto C; Cifarelli A; Pandolfi C; De Felice F; Fiorilli R; Caferri G; Violini R
J Invasive Cardiol; 2009 Jun; 21(6):290-3. PubMed ID: 19494408
[TBL] [Abstract][Full Text] [Related]
32. Interatrial shunt closure devices in patients with nickel allergy.
Reddy BT; Patel JB; Powell DL; Michaels AD
Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
[TBL] [Abstract][Full Text] [Related]
33. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
Spies C; Strasheim R; Timmermanns I; Schraeder R
Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
[TBL] [Abstract][Full Text] [Related]
34. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single amplatzer device: feasibility of a new method.
Zanchetta M; Rigatelli G; Pedon L; Zennaro M; Carrozza A; Onorato E
J Invasive Cardiol; 2005 May; 17(5):262-5. PubMed ID: 15879606
[TBL] [Abstract][Full Text] [Related]
35. PFO closure in 2008: See through a glass, darkly.
Carroll JD
Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
[No Abstract] [Full Text] [Related]
36. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
[TBL] [Abstract][Full Text] [Related]
38. Closure of persistent foramen ovale with the BioSTAR biodegradable PFO closure device: feasibility and long-term outcome.
Karagianni A; Abrahamsson P; Furenäs E; Eriksson P; Dellborg M
Scand Cardiovasc J; 2011 Oct; 45(5):267-72. PubMed ID: 21728789
[TBL] [Abstract][Full Text] [Related]
39. [Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder].
Huang YG; Zhang CJ; Huang XS; Huang T; Huang WH
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1132-5. PubMed ID: 20193187
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]